Filing Details
- Accession Number:
- 0001493152-22-032557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-15 17:33:14
- Reporting Period:
- 2022-11-14
- Accepted Time:
- 2022-11-15 17:33:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1873835 | Immix Biopharma Inc. | IMMX | Pharmaceutical Preparations (2834) | 454869378 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1889334 | M Ilya Rachman | C/O Immix Biopharma, Inc. 11400 West Olympic Blvd., Suite 200 Los Angeles CA 90064 | Ceo And Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-14 | 4,050 | $1.02 | 906,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-14 | 1,000 | $0.95 | 907,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-11-14 | 150 | $0.99 | 907,700 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |